Skip to content

Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care

A Randomized Controlled Pilot: Use of Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01296841
Enrollment
34
Registered
2011-02-16
Start date
2009-10-31
Completion date
2010-06-30
Last updated
2017-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis

Keywords

telemedicine, remote consultation, telehealth, ehealth, image archiving, inflammatory bowel disease

Brief summary

The investigators hypothesize that outpatient clinical care of Inflammatory Bowel Disease patients may be provided using a new computerized system over standard network - called Collaborative Imaging - with similar patient experience compared to a conventional clinic visit.

Detailed description

Significant advances in gastroenterology have led the field to grow into a number of advanced subspecialties: inflammatory bowel disease (IBD), motility, therapeutic endoscopy, and transplant hepatology. Telemedicine, the application of information technology in support of health care delivery from a distance, has been employed with good success in various chronic conditions with excellent patient satisfaction. Primary Aim: Our primary study endpoint was measuring patient clinical experience between two groups: A telemedicine remote clinic visit and a standard in-house visit. Secondary Aim: To compare standard clinic metrics including clinic wait time, patient throughput, and appointment time between the two groups.

Interventions

DEVICECollaborative Imaging

Hardware and software communication tools to provide clinical care from a distance.

Sponsors

VA Palo Alto Health Care System
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (\> 18 years old) outpatient IBD patients in the Veterans Affairs medical system

Exclusion criteria

* VA patients without IBD * Hospitalized IBD patients

Design outcomes

Primary

MeasureTime frameDescription
Patient Clinical ExperienceClinic VisitWe used a validated Ware Specific Visit Questionnaire to assess patients' satisfaction with their clinic-visit encounter. This is a 14-item questionnaire on doctor-patient interaction including factors such as attention to complaints, technical skills, and personal manner (courtesy,and ease of appointment scheduling and is based on a five-point Likert scale (1 excellent to 5 poor). Patients completed the questionnaire at the time of the visit. The 14 item scores were individually scored and then averaged to provide the final overall value.

Secondary

MeasureTime frameDescription
Clinic Appointment DurationClinic VisitThe investigators recorded appointment duration in minutes.
Clinic Appointment Wait TimeClinic VisitThe investigators recorded clinic appointment wait time duration in minutes

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard Encounter
Standard in-house clinical visit between patient and physician.
19
Telemedicine Encounter
Remote clinical appointment between patient and physician.
15
Total34

Baseline characteristics

CharacteristicTelemedicine EncounterStandard EncounterTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
6 Participants4 Participants10 Participants
Age, Categorical
Between 18 and 65 years
9 Participants15 Participants24 Participants
Age, Continuous62.8 years
STANDARD_DEVIATION 11.5
58.5 years
STANDARD_DEVIATION 9.6
60.4 years
STANDARD_DEVIATION 10.5
Gender
Female
2 Participants6 Participants8 Participants
Gender
Male
13 Participants13 Participants26 Participants
Region of Enrollment
United States
15 participants19 participants34 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 190 / 15
serious
Total, serious adverse events
0 / 190 / 15

Outcome results

Primary

Patient Clinical Experience

We used a validated Ware Specific Visit Questionnaire to assess patients' satisfaction with their clinic-visit encounter. This is a 14-item questionnaire on doctor-patient interaction including factors such as attention to complaints, technical skills, and personal manner (courtesy,and ease of appointment scheduling and is based on a five-point Likert scale (1 excellent to 5 poor). Patients completed the questionnaire at the time of the visit. The 14 item scores were individually scored and then averaged to provide the final overall value.

Time frame: Clinic Visit

Population: per protocol

ArmMeasureValue (MEAN)Dispersion
TelemedicinePatient Clinical Experience1.2 units on a scaleStandard Deviation 0.4
StandardPatient Clinical Experience1.3 units on a scaleStandard Deviation 0.5
p-value: <0.05t-test, 2 sided
Secondary

Clinic Appointment Duration

The investigators recorded appointment duration in minutes.

Time frame: Clinic Visit

Population: Pilot.

ArmMeasureValue (MEAN)Dispersion
TelemedicineClinic Appointment Duration59 MinutesStandard Deviation 18
StandardClinic Appointment Duration60 MinutesStandard Deviation 25
Secondary

Clinic Appointment Wait Time

The investigators recorded clinic appointment wait time duration in minutes

Time frame: Clinic Visit

ArmMeasureValue (MEAN)Dispersion
TelemedicineClinic Appointment Wait Time18 minutesStandard Deviation 14.5
StandardClinic Appointment Wait Time25 minutesStandard Deviation 25

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026